Clinical Trial Update: Semaglutide in Women With Polycystic Ovary Syndrome and Obesity [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update shows ongoing Phase 2 and Phase 3 trials of semaglutide for women with polycystic ovary syndrome and obesity, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Polycystic Ovary Syndrome

Drugs mentioned

• semaglutide (semaglutide)

Snippet

Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | Conditions: Polycystic Ovary Syndrome (PCOS) Women, Obesity | Phase 2, Phase 3 | Status: RECRUITING